Cita APA (7a ed.)
Aoki, M., Naiki, T., Naiki-Ito, A., Morikawa, T., Matsuyama, N., Torii, K., . . . Yasui, T. (Mar 2024). Successful treatment with enfortumab–vedotin of metastatic signet ring cell cancer expressing nectin-4 and originating from the bladder. IJU Case Reports. https://doi.org/10.1002/iju5.12678
Cita Chicago Style (17a ed.)
Aoki, Maria, et al. "Successful Treatment with Enfortumab–vedotin of Metastatic Signet ring Cell Cancer Expressing Nectin-4 and Originating from The bladder." IJU Case Reports Mar 2024. https://doi.org/10.1002/iju5.12678.
Cita MLA (9a ed.)
Aoki, Maria, et al. "Successful Treatment with Enfortumab–vedotin of Metastatic Signet ring Cell Cancer Expressing Nectin-4 and Originating from The bladder." IJU Case Reports, Mar 2024, https://doi.org/10.1002/iju5.12678.
Precaución: Estas citas no son 100% exactas.